Proyectos Anteriores

Proyectos en el Mundo

2011

  • IMW 2011. Paris, France. NOVARTIS ONCOLOGY – PANOBINOSTAT
  • WCD 2011. Seoul, Korea. MERCK/MSD – REMICADE
  • SICOT 2011. Prague, Czech Republic. MERCK/MSD – ARCOXIA
  • PRSFS 2011. Hong Kong, China. MERCK / MSD – NUVARING & IMPLANON

2010

  • IASLC 2010. Geneva, Switzerland. NOVARTIS ONCOLOGY – ZOMETA
  • ISHL 2010. Cologne, Germany. NOVARTIS ONCOLOGY – PANOBINOSTAT
  • IFFS 2010. Munich, Germany. MERCK/MSD – PUREGON, ELONVA & ORGALUTRAN
  • LATAM KICK OFF SALES MEETING. Rome, Italy. NOVARTIS ONCOLOGY – ALL ONCOLOGY BRANDS

2009

  • AHS/IHC 2009. Philadelphia, Pennsylvania. PFIZER – RELPAX
  • IFOS 2009. Sao Paulo, Brazil. MERCK/MSD – AERIUS & NASONEX
  • WAC 2009. Buenos Aires, Argentina. MERCK/MSD – AERIUS & NASONEX

2008

  • ENEA 2008. Antalia, Turkey. NOVARTIS ONCOLOGY USA – SANDOSTATIN
  • ICE 2008. Rio de Janeiro, Brasil. NOVARTIS ONCOLOGY USA – SANDOSTATIN

2007

  • ENDO Meeting. Toronto. Canada.NOVARTIS
  • PAS CONGRESS. Toronto, Canada.PFIZER.
  • SIU 2007 Cape Tawn, Sud Africa.NOVARTIS – ZOMETA
  • WDC CONGRESS. Buenos Aires, Argentina.SCHERING PLOUGH.
  • WORLD LUNG CANCER CONGRESS. Seoul, Korea.NOVARTIS – ZOMETA

2006

  • World Cardiology Congress. Barcelona. Spain FERRER INTERNATIONAL

2005

  • World Myeloma Congress. Sidney, Australia. NOVARTIS ONCOLOGY
  • World Allergy Congress. Munich, Germany SCHERING PLOUGH

2004

  • World AIDS Congress. Bangkok, Thailand. BRISTOL MAYERS SQUIB
  • World Endocrinology Congress. Lisbon, Portugal. NOVARTIS ONCOLOGY

2011

  • ASCO 2011. Chicago, IL. BAYER – GLOBAL CLINICAL TRIALS
  • AACE 2011. San Diego, CA. NOVARTIS ONCOLOGY – SANDOSTATIN
  • DDW 2011. Chicago, IL. NOVARTIS ONCOLOGY – NETALLIANCE
  • ASCO 2011. Chicago, IL. NOVARTIS ONCOLOGY – NETALLIANCE, PANOBINOSTAT & SANDOSTATIN
  • ENDO 2011. Boston, MA. NOVARTIS ONCOLOGY – SANDOSTATIN
  • ACOG 2011. Washington, DC. MERCK/MSD – NUVARING & IMPLANON
  • APA 2011. Honolulu, Hawaii. MERCK/MSD – SAPHIRS
  • IPS 2011. San Francisco, CA. MERCK/MSD – SAPHIRS
  • US PSYCHIATRIC AND MENTAL CONGRESS 2011. Las Vegas, NV. MERCK/MSD – SAPHIRS

2010

  • AACE 2010. Boston, MA. NOVARTIS ONCOLOGY – SANDOSTATIN
  • ASCO 2010. Chicago, IL. NOVARTIS ONCOLOGY – SANDOSTATIN
  • ASCO 2010. Chicago, IL. NOVARTIS ONCOLOGY – NETALLIANCE
  • ASCO 2010. Chicago, IL. NOVARTIS ONCOLOGY – FEMARA
  • ASCO 2010. Chicago, IL. MERCK/MSD – CAELYX
  • ENDO 2010. Boston, MA. NOVARTIS ONCOLOGY – SANDOSTATIN
  • DDW 2010. New Orleans, LA. NOVARTIS ONCOLOGY – NETALLIANCE
  • ACG 2010. San Antonio, TX. NOVARTIS ONCOLOGY – NETALLIANCE
  • ASRM 2010. Denver, CO. MERCK/MSD – ORGALUTRAN, ELONVA & PUREGON

2009

  • AUA 2009. Chicago Illinois. NOVARTIS ONCOLOGY – ZOMETA, AFINITOR & PROLEUKIN
  • ASCO 2009. Orlando, Florida. NOVARTIS ONCOLOGY – FEMARA & PROLEUKIN
  • ASCO 2009. Orlando, Florida. MERCK/MSD – INTRONA & TEMODAL
  • SABCS 2009. San Antonio, Texas. NOVARTIS ONCOLOGY – FEMARA
  • PRIMED SOUTH 2009. Fort Lauderdale, Florida. PFIZER – RELPAX
  • AAOS 2009. Las Vegas, Nevada. PFIZER – RELPAX
  • ACR 2009. Philadelphia, Pennsylvania. MERCK/MSD – REMICADE
  • DIA 2009. San Diego, California. PERCEPTIVE INFORMATICS
  • AACE 2009. United States. NOVARTIS ONCOLOGY – SANDOSTATIN
  • ASCO 2009. United States. NOVARTIS ONCOLOGY – SANDOSTATIN
  • ENDO 2009. United States. NOVARTIS ONCOLOGY – SANDOSTATIN
  • ACG 2009. United States. NOVARTIS ONCOLOGY – SANDOSTATIN

2008

  • PRIMED. Rosemond, IL. ChicagoNOVARTIS ONCOLOGY USA – SANDOSTATIN – REACT
  • AACE2008. Orlando. NOVARTIS ONCOLOGY USA – SANDOSTATIN
  • DDW 2008. Orlando. NOVARTIS ONCOLOGY USA – SANDOSTATIN- REACT
  • AUA 2008. Orlando. NOVARTIS ONCOLOGY USA – ZOMETA
  • ASCO 2008. Chicago. SCHRING PLOUGH

2007

  • ASCO 2007. Chicago. CELGENE
  • ASCO 2007 Chicago. NOVARTIS ONCOLOGY USA
  • ENDO 2007 San Francisco. NOVARTIS ONCOLOGY USA – SANDOSTATIN
  • PRIMED. Boston. NOVARTIS ONCOLOGY USA – SANDOSTATIN – REACT
  • DDW. Washinton. NOVARTIS ONCOLOGY USA – SANDOSTATIN
  • DDW. Washinton.ROCHE PHARMA.
  • ASCO 2007. Chicago. NOVARTIS ONCOLOGY USA Zometa, Femara, Sandostatin and Proleukin
  • AUA 2007.Anaheim, CA. NOVARTIS ONCOLOGY USA- Zometa, Proleukin
  • REACT 2007 New York. NOVARTIS ONCOLOGY USA
  • REACT 2007. Boston. NOVARTIS ONCOLOGY USA
  • SABCS CONGRESS. Atlanta. NOVARTIS ONCOLOGY USA EXJADE
  • SABCS CONGRESS. San Antonio. Texas.NOVARTIS ONCOLOGY USA.

2006

  • DDW. Los Angeles, CA. ROCHE
  • AUA. AtlantaGA. NOVARTIS ONCOLOGY
  • ENDO. Boston, MA. NOVARTIS ONCOLOGY
  • ACG. Las Vegas. NV ROCHE
  • AASLD. Boston. MA ROCHE
  • ASH. Orlando. FL CELGEN

2005

  • AUA. San Antonio. TX BAYER NOVARTIS
  • ONCOLOGY AASLD. San Francisco, CA ROCHE

2004

  • AHA. New Orleans, LA BRISTOL MYERS SQUIBB

2011

  • ENETS 2011. Lisbon, Portugal. NOVARTIS ONCOLOGY – SANDOSTATIN
  • ST. GALLEN 2011. St. Gallen, Switzerland. NOVARTIS ONCOLOGY – ZOMETA
  • EAU 2011. Vienna, Austria. NOVARTIS ONCOLOGY – AFINITOR
  • GIST RISK IPAD QUIZ APP. NOVARTIS ONCOLOGY – GIST
  • ECE 2011. Rotterdam, Netherlands. NOVARTIS ONCOLOGY – SANDOSTATIN
  • EKCA 2011. Warsaw, Poland. NOVARTIS ONCOLOGY – AFINITOR
  • 24-MONTH COMPETITION. NOVARTIS ONCOLOGY – TASIGNA
  • EHA 2011. London, England. NOVARTIS ONCOLOGY – PANOBINOSTAT
  • ESMO 2011. Stockholm, Sweden. NOVARTIS ONCOLOGY – GIST
  • ENEWSFLASH 2011. Interactive Online eNewsletter. NOVARTIS ONCOLOGY – LBH 589
  • EIR 2011. Instanbul, Turkey. MERCK/MSD – REMICADE
  • ECCO 2011. Dublin, Ireland. MERCK/MSD – REMICADE
  • EULAR 2011. London, England. MERCK/MSD – REMICADE, SIMPONI & ARCOXIA
  • ESA 2011. Amsterdam, Netherlands. MERCK/MSD – BRIDION
  • EFIC 2011. Hamburg, Germany. MERCK/MSD – ARCOXIA
  • EADV 2011. Lisbon, Portugal. MERK/MSD – REMICADE, PROPECIA & ELOCOM
  • UEGW 2011. Stockholm, Sweden. MERCK/MSD – REMICADE

2010

  • ENETS 2010. Berlin, Germany. NOVARTIS ONCOLOGY – SANDOSTATIN
  • EBCC 2010. Barcelona, Spain. NOVARTIS ONCOLOGY – ZOMETA & FEMARA
  • ECE 2010. Prague, Czech Republic. NOVARTIS ONCOLOGY – SANDOSTATIN
  • IMPAKT 2010. Brussels, Belgium. NOVARTIS ONCOLOGY
  • EHA 2010. Barcelona, Spain. NOVARTIS ONCOLOGY – TASIGNA, EXJADE, PANOBINOSTAT & ZOMETA
  • ESMO 2010. Milan, Italy. NOVARTIS ONCOLOGY – ZOMETA, SANDOSTATIN, FEMARA, AFINITOR, NETALLIANCE & GLIVEC
  • ENEWSFLASH 2010. Interactive Online eNewsletter. NOVARTIS ONCOLOGY – LBH 589
  • ZOMETA.COM 2010. Maintanance. NOVARTIS ONCOLOGY – ZOMETA
  • ECCO 2010. Prague, Czech Republic. MERCK/MSD – REMICADE
  • ESA 2010. Helsinki, Finland. MERCK/MSD – BRIDION
  • EULAR 2010. Rome, Italy. MERCK/MSD – REMICADE & SIMPONI
  • ESHRE 2010. Rome, Italy. MERCK/MSD – PUREGON, ELONVA & ORGALUTRAN
  • EADV 2010. Gothenburg, Sweden. MERCK/MSD – REMICADE
  • UEGW 2010. Barcelona, Spain. MERCK/MSD – REMICADE
  • ZENITH 2010. Vienna, Austria. NOVARTIS ONCOLOGY

2009

  • ZENITH MEETING 2009. Seville, Spain. NOVARTIS ONCOLOGY – ONCOLOGY PRODUCTS
  • ST. GALLEN 2009. St. Gallen, Switzerland. NOVARTIS ONCOLOGY – FEMARA & ZOMETA
  • EAU 2009. Stockholm, Sweden. NOVARTIS ONCOLOGY – ZOMETA
  • ECE 2009. Istanbul, Turkey. NOVARTIS ONCOLOGY – SANDOSTATIN, FEMARA & PROLEUKIN
  • ECCO/ESMO 2009. Berlin, Germany. NOVARTIS ONCOLOGY – ZOMETA, FEMARA & NETALLIANCE
  • ESA 2009. Milan, Italy. MERCK/MSD – BRIDION
  • EAACI 2009. Warsaw, Poland. MERCK/MSD – AERIUS & NASONEX
  • EULAR 2009. Copenhagen, Denmark. MERCK/MSD – REMICADE
  • ESHRE 2009. Amsterdam, Netherlands. MERCK/MSD – PUREGON
  • ECCO/ESMO 2009. Berlin, Germany. MERCK/MSD – INTRONA & CAELYX
  • EADV 2009. Berlin, Germany. MERCK/MSD – REMICADE & AERIUS
  • UEGW 2009. London, England. MERCK/MSD – REMICADE

2008

  • EAU 2008. Milan. Italy. NOVARTIS ONCOLOGY USA – ZOMETA
  • EAU 2008. Milan. Italy. PFIZER – USA – VIAGRA
  • EBCC 2008. Berlin. Germany. NOVARTIS ONCOLOGY USA – ZOMETA – FEMARA
  • ECE 2008. Berlin. Germany. NOVARTIS ONCOLOGY USA – SANDOSTATIN
  • EULAR 2008. Paris. France. SCHRING PLOUGH
  • EUGW 2008. Viena. Austria. SCHRING PLOUGH

2007

  • EAU 2008. Berlin. Germany.NOVARTIS ZOMETA
  • ZENITH Meeting. Prague, Czesh Republic. NOVARTIS
  • EAACI 2007. Gotteborg Sweden. SCHRING PLOUGH
  • UEGW CONGRESS. Paris. SCHERING PLOUGH
  • EUROPEAN CONGRESS OF DERMATOLOGY. Viena, Austria. FERRER
  • EUROPEAN CONGRESS OF CARDIOLOGY. Viena, Austria.FERRER

2006

  • EBCC. Nice, France. NOVARTIS
  • EAACI. Vienna. Austria SCHERING PLOUGH
  • EHA. Amsterdam. Holland CELGENE
  • ESMO. Istanbul. Turkey NOVARTIS ONCOLOGY

2005

  • PRIMARY THERAPY OF EARLY BREAST CANCER. ST. Gallen, Switzerland. NOVARTIS
  • EHA. Stockholm, Sweden CELGENE
  • EUGW. Copenhagen, Denmark. CASEN
  • EAU. Istanbul, Turkey. NOVARTIS
  • ECCO. Paris, France. NOVARTIS
  • ECCO. Paris, France. CELGENE
  • FBA. Düsseldorf. NOVARTIS
  • DGE – MÜNSTER. NOVARTIS

2004

  • WHAT IS NEW IN BISPHOSPHONATES. Davos, Switzerland. NOVARTIS
  • EULAR. Berlin, Germany. ALMIRALL
  • EUGW. Prague, Czech Republic. CASEN SCHERING PLOUGH
  • ESMO. Vienna, Austria NOVARTIS

2011

  • SEN 2001. Sevilla. ABBOTT – ZEMPLAR
  • CASOS CLÍNICOS EN RESPIRATORIO VOL. 1. ALMIRALL – PLUSVENT
  • CASOS CLÍNICOS EN RESPIRATORIO VOL. 2. ALMIRALL – PLUSVENT
  • CASOS CLÍNICOS EN RESPIRATORIO VOL. 3. ALMIRALL – PLUSVENT
  • CASOS CLÍNICOS EN RESPIRATORIO VOL. 4. ALMIRALL – PLUSVENT
  • NEUMO UPDATE VOL. 1. ALMIRALL – PLUSVENT
  • NEUMO UPDATE VOL. 2. ALMIRALL – PLUSVENT
  • NEUMO UPDATE VOL. 3. ALMIRALL – PLUSVENT
  • DIAGNÓSTICO POR IMÁGEN. Compendio con las 5 entregas. ALMIRALL – PLUSVENT
  • ENFERMEDADES RESPIRATORIAS 2011. Barcelona. ALMIRALL – PLUSVENT
  • SEPAR 2011. Oviedo. ALMIRALL – PLUSVENT
  • SEMG 2011. Vigo. ASTRAZENECA – SYMBICORT, NEXIUM, ATACAND & CRESTOR
  • SEMI 2011. Maspalomas. ASTRAZENECA – SYMBICORT, NEXIUM, ATACAND & CRESTOR
  • SEMERGEN 2011. Oviedo. ASTRAZENECA – SYMBICORT, NEXIUM, ATACAND & CRESTOR
  • AEDV 2011. Santiago de Compostela. MSD – REMICADE
  • ACTUALIDAD TRAUMATOLOGÍA. Tenerife. PFIZER – CELEBREX
  • SECMA 2011. Valencia. PFIZER – XIAPEX
  • SECPRE 2011. Murcia. PFIZER – XIAPEX
  • SER 2011. Málaga. PFIZER – ENBREL

2010

  • CASOS CLÍNICOS EN RESPIRATORIO VOL. 2. ALMIRALL – PLUSVENT
  • CASOS CLÍNICOS EN RESPIRATORIO VOL. 3. ALMIRALL – PLUSVENT
  • CASOS CLÍNICOS EN RESPIRATORIO VOL. 4. ALMIRALL – PLUSVENT
  • CASOS CLÍNICOS EN RESPIRATORIO VOL. 5. ALMIRALL – PLUSVENT
  • MONOGRAFÍA TABACO VOL. 0. ALMIRALL – PLUSVENT
  • ENFERMEDADES RESPIRATORIAS 2010. Barcelona. ALMIRALL – PLUSVENT
  • AEDV 2010. Málaga. ALMIRALL – ALL DERMATOLOGY BRANDS
  • SEPAR 2010. A Coruña. ALMIRALL – PLUSVENT
  • SEAIC 2010. Madrid. ALMIRALL – PLUSVENT
  • SED 2010. Barcelona. ASTRAZENECA – ONGLYZA
  • SEMG 2010. Granada. ASTRAZENECA – SYMBICORT, NEXIUM, ATACAND & CRESTOR
  • SEMERGEN 2010. Maspalomas. ASTRAZENECA – SYMBICORT, NEXIUM, ATACAND & CRESTOR
  • SEMI 2010. Oviedo. ASTRAZENECA – SYMBICORT, NEXIUM, ATACAND & CRESTOR
  • SEC 2010. Valencia. PFIZER – CADUET, LIPITOR, CHAMPIX & INSPRA
  • POSTER MAKER SOFTWARE. URIACH – PAFINUR

2009

  • DIAGNÓSTICO Y TRATAMIENTO ENFERMEDADES RESPIRATORIAS VOL. 5. ALMIRALL – PLUSVENT
  • DIAGNÓSTICO Y TRATAMIENTO ENFERMEDADES RESPIRATORIAS VOL. 6. ALMIRALL – PLUSVENT
  • DIAGNÓSTICO Y TRATAMIENTO ENFERMEDADES RESPIRATORIAS VOL. 7. ALMIRALL – PLUSVENT
  • DIAGNÓSTICO Y TRATAMIENTO ENFERMEDADES RESPIRATORIAS VOL. 8. ALMIRALL – PLUSVENT
  • DIAGNÓSTICO POR IMÁGEN DEL TORAX VOL. 5. ALMIRALL – PLUSVENT
  • ENFERMEDADES RESPIRATORIAS 2009. Barcelona. ALMIRALL – PLUSVENT
  • SEPAR 2009. Santander. ALMIRALL – PLUSVENT
  • MONOGRAFÍA GRIPE A Vol. 0. ALMIRALL – PLUSVENT
  • MONOGRAFÍA GRIPE A Vol. 1. ALMIRALL – PLUSVENT
  • SED 2009. Tenerife. ASTRAZENECA – ONGLYZA
  • SEMG 2009. Oviedo. ASTRAZENECA – ONGLYZA
  • SEMFYC 2009. Barcelona. ASTRAZENECA – ONGLYZA
  • SEN 2009. Barcelona. ESTEVE – PROMETAX
  • SER 2009. Murcia. LACER – GALAXDAR
  • SEACV 2009. Valencia. LACER – GALAXDAR
  • SECOT 2009. Barcelona. LACER – GALAXDAR
  • ELIVROS – Electronic Lipitor vs Rosubastatin Session. PFIZER – LIPITOR
  • POSTER MAKER SOFTWARE. URIACH – RUPAFIN

2008

  • EACCI 2008. Barcelona. SCHRING PLOUGH
  • CONGRESO SEHLELHA. Valencia. ESTEVE
  • CONGRESO SEHLELHA. Valencia. BOEHRINGER
  • SYMPOSIUM ENFERMEDADES RESPIRATORIAS. Barcelona. ALMIRALL
  • SEPAR 2008. Tenerife. ALMIRALL
  • EAIC. Bilbao.ALMIRALL
  • REUNION ENFERMEDADES RESPIRATORIAS. Barcelona. ALMIRALL
  • SEH-LELHA. Valencia. ALMIRALL

2007

  • ECCO CONGRESS. Barcelona. NOVARTIS – ZOMETA, FEMARA
  • ACG REACT CONGRESS. Madrid. NOVARTIS
  • EASL Congress Pegchalenge. Barcelona. SCHERING PLOUGH
  • EULAR 2007. Barcelona. SCHERING PLOUGH
  • SEPAR 2007. Barcelona. ALMIRALL
  • SEAIC 2007. Santander. ALMIRALL
  • CONGRESO NACIONAL DE PSIQUIATRÍA 2007. Valencia. ALMIRALL
  • CONGRESO NACIONAL DE DERMATOLOGÍA. Granada. FERRER
  • CONGRESO NACIONAL DE DERMATOLOGÍA. Madrid. FERRER
  • SER 2007. Granada.MERK
  • SEGO 2007. Granada.MERK
  • SECOT 2007. Madrid.MERK
  • SEC 2007. Madrid.MERK
  • CONGRESO DE LA SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGIA 2007. Murcia. PFIZER
  • ECCO 2007. Barcelona. PHARMAMAR

2006

  • SEH-LELHA. Madrid. ALMIRALL
  • SEEN. Sevilla. MERCK – PFIZER
  • SED. Madrid. MERCK – PFIZER
  • SEPAR. Sevilla. ALMIRALL
  • SEAIC. Valencia. ALMIRALL
  • SEPD. Granada. MERCK
  • SER. Valencia. MERCK – NOVARTIS

2005

  • SEPAR. Madrid. ALMIRALL
  • SEAIC. Sevilla. ALMIRALL
  • SER. Las Palmas de G.C. MERCK
  • SEGO. La Coruña. MERCK
  • SEEN. Madrid. MERCK – PFIZER
  • SEPD. Madrid. MERCK
  • SECOT. Sevilla. MERCK
  • SEC. Barcelona. MERCK
  • AEDV. Salamanca. SALVAT

2004

  • SEPAR. Madrid. ALMIRALL
  • SEAIC. Marbella. ALMIRALL
  • SEP. Bilbao. FERRER – SANOFI-SYNTHELABO
  • AEDV. Sevilla. MENARINI – SALVAT
  • SEPD. Valencia. MERCK
  • SECOT. Madrid. MERCK
  • SEC. Madrid. MERCK – SANOFI-SYNTHELABO
  • SEN. Barcelona, NOVARTIS
  • SENF. Oviedo. SALVAT

2003

  • INFARMA. Barcelona. ALMIRALL
  • SHE-LELHA. Madrid. ALMIRALL
  • AEU. Sta Cruz de Tenerife. ALMIRALL
  • SEPAR. Zaragoza. ALMIRALL
  • SEN. Palma de Mallorca. AMGEN – SANOFI- SYNTHELABOSER. Bilbao. JANSSEN-CILAG
  • SECOT. Tenerife. JANSSEN-CILAG – SANOFI – SYNTHELABO
  • SEP. Mallorca. SANOFI – SYNTHELABO

2002

  • SHE-LELHA. Madrid. ALMIRALL
  • AEU. Murcia. ALMIRALL
  • SERMEF. San Sebastián. ALMIRALL
  • SER. Oviedo. ALMIRALL – PFIZER
  • SEPAR. Las Palmas de G.C. ALMIRALL – BOEHRINGER INGELHEIM
  • SEMG. Madrid. ALMIRALL
  • SECOT. Barcelona. ALMIRALL – AVENTIS – ROTTAPHARM – SANOFI-SYNTHELABO
  • SEAIC. Madrid. ALMIRALL
  • SEMERGEN. Salamanca. ALMIRALL
  • SEC. Madrid. ALMIRALL – PFIZER
  • SEMFYC. Madrid. PFIZER

2001

  • AEU. Granada. ALMIRALL
  • SEPAR. La Coruña. ALMIRALL – ALTER
  • SEGO. Valencia. ALMIRALL
  • SER. Madrid. ALMIRALL – PHARMACIA
  • SEGG. Barcelona. ALMIRALL
  • SECOT. Bilbao. ALMIRALL – PFIZER
  • SEC. Barcelona. ALMIRALL
  • SERMEF. Granada. PFIZER
  • SEMG. Santander. PFIZER
  • SEMFYC. San Sebastián. PFIZER – PHARMACIA
  • SEMERGE. Alicante. PHARMACIA

2000

  • AEU. Madrid. ALMIRALL
  • SEGO. Barcelona. ALMIRALL
  • SEGG. Barcelona. ALMIRALL
  • SECOT. Madrid. ALMIRALL-BOEHRINGER INGELHEIM – SEARLE
  • SEP. Zaragozna. ALMIRALL
  • SER. Santiago de Compostela BOEJRINGER INGELHEIM – SEARLE
  • SEEN. Salamanca. ROCHE
  • SED. Bilbao. ROCHE
  • SEC. Granada. ROCHE
  • SEMFYC. Gijón. ROCHE
  • SEMERGEN. Santiago Compostela. SEARLE

1999

  • AEU. Zaragoza. ALMIRALL
  • SEGO. Zaragoza. ALMIRALL
  • SEN. Valencia. ALMIRALL – PFIZER
  • SECOT. Valencia. ALMIRALL
  • SEDAR. Sevilla. ASTRA ZENECA
  • SEPAR. Barcelona. ASTRA ZENECA
  • SEPD. Madrid. ASTRA ZENECA
  • SEAIC. La Coruña. ASTRA ZENECA
  • SEC. Sevilla. ASTRA ENECA
  • SEMFYC. Tenerife. ASTRA ZENECA – ROCHE
  • SEP. Oviedo. PFIZER

1998

  • SER. Canarias. ROTTAPHARM
  • SECOT. Santander. ROTTAPHARM
  • WEBSITE. Premio Glaxo Wellcome en Neurología – GSK
Scroll to Top